Showing results (91-100 of 497) with videos related to

Sort By:
Pageof 50
Oncotarget|December 31, 2016
Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and BtkJoo Hyun Kim, Won Seog Kim, Jung Yong Hong, et al.
Blood Cancer Journal|June 29, 2026
Circulating CD20-positive extracellular vesicles impair rituximab efficacy and predict outcomes in diffuse large B-cell lymphomaBon Park, Kyung Ju Ryu, Min Kyu Choi, et al.
Cancer Research and Treatment|July 11, 2018
Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular LymphomaHansang Lee, Dongryul Oh, Kyungmi Yang, et al.
Human Pathology|March 27, 2021
MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphomaYoon Ah Cho, Jiyeon Hyeon, Hyunwoo Lee, et al.
Hepato-Gastroenterology|October 25, 2011
Primary gastrointestinal follicular lymphoma: single-center 12-year experiencesYoun Ju Na, Eun Ran Kim, Seok Jin Kim, et al.
Medicine|November 9, 2019
Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997-2016: An observational studyJongmin Sim, Takuya Takayama, Junhun Cho, et al.
Cytokine|March 6, 2020
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphomaJun Ho Yi, Sang Eun Yoon, Kyung Ju Ryu, et al.
Anticancer Research|July 31, 2014
Renal Insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statementSilvia Park, Boram Han, Kihyun Kim, et al.
Journal of Korean Medical Science|April 26, 2008
The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groupsEun-Yoon Cho, Ki-Hyun Kim, Won-Seog Kim, et al.
Nutrition and Cancer|January 11, 2014
Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOPSilvia Park, Boram Han, Jae Won Cho, et al.
Pageof 50